APOA1 and coronary artery disorder: Also, the adjusted risk of CAD was higher for patients with FT3 ≤ 4.5 pmol/L (Group 3) than for those with a low HDL-C/apoA-I ≤ 0.89 mmol/g (Group 2), as Fig. 2 shows.